Overview
Kishio Toma practices practicing medicine in Okayama, Japan.
Their clinical expertise encompasses Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) and Autoimmune Polyglandular Syndrome Type 2.
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kishio Toma
Is Kishio Toma a top-rated expert for Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)?
MediFind is an objective health platform that identifies experts based on real-world data. Kishio Toma is classified as an Experienced expert for Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kishio Toma participate in research or clinical trials?
Yes. Kishio Toma has published 14 articles and abstracts on conditions like Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED). You can view a list of Kishio Toma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)
- Autoimmune Polyglandular Syndrome Type 2